The Health division of Wolters Kluwer, a global provider of information and point of care solutions for the healthcare industry, is once again enhancing its Lexicomp® drug information reference solutions with new content and features. All enhancements are intended to make Lexicomp Online and Lexicomp Mobile Apps more efficient and add to the wealth of information and tools healthcare professionals trust to support their medication decisions and help them reduce errors.
Chief among the recent enhancements is the addition of drug class monographs. Available to subscribers to the Formulary Decision Support Bundle of additional, specialized tools, drug class monographs feature details about drug properties common to given pharmacologic classes to assist professionals with drug therapy decisions. Links to class monographs have been added to more than 550 monographs in the Lexicomp core drug information database.
Other recent enhancements include: in-line referencing added to "Uses: Off-label" field in core drug monographs; new drug pricing field in pediatric and neonatal drug monographs to improve workflow efficiency; multinational drugs added to Toxicology module to support a more global view of medication safety; and addition of Brazilian and International Nonproprietary Names to architecture to support more effective searching in languages other than English.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
